QR-Code

No fault vaccine injury compensation after COVID-19: A systematic literature review and proposed typology

The COVID-19 pandemic brought about a unique and rapid period of global vaccine innovation. It revealed structural challenges not only in global vaccine affordability and distribution but in the liability and indemnity structures that can both impede access and affect fair outcomes for the small num...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Sam Halabi, Nishtha Arora, Alison Durran, Qianhan Qian, Shabna Ummer, Katherine Ginsbach, Kashish Aneja
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis Group 2026-12-01
Schriftenreihe:Human Vaccines & Immunotherapeutics
Schlagworte:
COVID-19
vaccine indemnity
liability
no-fault compensation schemes (NFCS)
GAVI COVAX AMC
vaccine innovation
Online-Zugang:https://www.tandfonline.com/doi/10.1080/21645515.2026.2620849
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge